Solana Co. is a medical device firm specializing in neurotechnology, dedicated to improving neurological wellness. The company's strategy involves developing, licensing, and acquiring innovative, non-invasive platform technologies. These technologies are designed to enhance the brain's intrinsic capacity for self-healing and mitigate the effects of neurological diseases or trauma. A prime example of their work is the development of an investigational portable neuromodulation stimulator. This device uniquely delivers neurostimulation through the tongue. Clinical studies have indicated that this…
| Price | $2.71 |
|---|---|
| Market cap | $158.23M |
| Sector | Financial Services |
| Industry | Asset Management |
| Exchange | NASDAQ |
| 52-week range | 1.185-24.99 |
| Beta | 1.07 |
Explore HSDT's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.